CG Oncology Growth Metrics (2023-2025) | CGON

Growth Metrics Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
EBITDA Margin Growth (1y) 0.08M9.02M192.72M-7.69M6.27M
EBITDA Margin (QoQ) -177.95M193.13M-1.90M-4.25M5.75M-7.28M
EBIT Margin Growth (1y) 0.08M9.02M192.72M-7.69M6.27M
EBIT Margin (QoQ) -177.95M193.13M-1.90M-4.25M5.75M-7.28M
EBT Margin Growth (1y) 0.13M8.32M164.81M-6.31M4.48M
EBT Margin (QoQ) -152.44M165.19M-1.38M-3.04M4.05M-5.93M
Enterprise Value Growth (1y) 738.14%-50.05%-14.84%20.14%
Enterprise Value (QoQ) 1,356.87%-34.25%28.32%-39.82%-1.63%12.11%81.03%
FCF Margin Growth (1y) -0.08M9.92M145.99M-5.15M3.47M
FCF Margin (QoQ) -132.83M145.96M-0.96M-2.25M3.24M-5.18M
Net Margin Growth (1y) 0.32M14.71M224.20M-6.31M4.48M
Net Margin (QoQ) -205.44M224.58M-1.38M-3.04M4.05M-5.93M
Operating Margin Growth (1y) 0.08M9.02M192.72M-7.69M6.27M
Operating Margin (QoQ) -177.95M193.13M-1.90M-4.25M5.75M-7.28M
Return on Assets Growth (1y) 0.00M-7.00-8.00
Return on Assets (QoQ) 3.00-2.000.00M-1.00-4.00-3.00
Return on Capital Employed Growth (1y) -1.00-8.00-9.00
Return on Capital Employed (QoQ) 3.00-3.000.00M-1.00-4.00-3.00
Return on Equity Growth (1y) 11.00-7.00-9.00
Return on Equity (QoQ) 14.00-2.000.00M-1.00-4.00-4.00
Return on Sales Growth (1y) -0.01M0.00M
Return on Sales (QoQ) -0.00M-773.000.00M-0.01M